Wells Fargo & Company MN Increases Stock Position in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Wells Fargo & Company MN grew its holdings in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 24.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 86,331 shares of the company’s stock after acquiring an additional 17,234 shares during the period. Wells Fargo & Company MN owned about 1.78% of SPDR S&P Pharmaceuticals ETF worth $3,711,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of XPH. Jones Financial Companies Lllp lifted its stake in SPDR S&P Pharmaceuticals ETF by 146.4% during the fourth quarter. Jones Financial Companies Lllp now owns 993 shares of the company’s stock worth $43,000 after purchasing an additional 590 shares during the last quarter. US Bancorp DE bought a new position in shares of SPDR S&P Pharmaceuticals ETF in the 4th quarter worth about $96,000. JPMorgan Chase & Co. lifted its position in shares of SPDR S&P Pharmaceuticals ETF by 36.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,443 shares of the company’s stock worth $197,000 after buying an additional 1,182 shares during the last quarter. Sigma Planning Corp acquired a new position in shares of SPDR S&P Pharmaceuticals ETF in the 4th quarter valued at about $221,000. Finally, SVB Wealth LLC bought a new stake in shares of SPDR S&P Pharmaceuticals ETF during the 4th quarter valued at about $267,000.

SPDR S&P Pharmaceuticals ETF Stock Up 2.3 %

Shares of NYSEARCA XPH opened at $38.91 on Wednesday. The firm’s 50-day moving average price is $42.02 and its two-hundred day moving average price is $44.03. SPDR S&P Pharmaceuticals ETF has a 52-week low of $35.22 and a 52-week high of $48.76. The stock has a market capitalization of $140.08 million, a P/E ratio of 14.47 and a beta of 0.67.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.